Drug Profile
BW 443C81
Alternative Names: 443c81; BW 443CLatest Information Update: 02 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antiasthmatics; Antitussives; Opioid analgesics
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 31 Aug 1999 Discontinued-Clinical for Asthma in United Kingdom (Inhalation)
- 27 Feb 1994 Investigation in Asthma in United Kingdom (Inhalation)